Infection-induced glucose starvation triggers NINJ1-dependent macrophage lysis and Candida escape Authors: Harshini Weerasinghe, Orawan Tulyaprawat, Helen Stölting, Johannes Sonnberger, Byron Mobbs, Joshua Nickson, Theresa Lange, Bryce van Denderen, Tricia L. Lo, Tim Bastian Schille, Françios A. B. Olivier, Natasha Kapoor-Kaushik, Timothy A. Gottschalk, Cathrine Hall, John Silke, James E. Vince, Kate E. Lawlor, Stefan Bröer, Kate Schroder, Sabrina Sofia Burgener, Bernhard Hube, Thomas Naderer, Adam J. Rose, Ana Traven Published: 2026 ABSTRACT Pathogens compete for glucose with macrophages, which disrupts host glycolysis, modulates antimicrobial responses and causes macrophage death. We show that glucose starvation induced by major fungal pathogens Candida albicans and Candida auris causes macrophage lysis by activating NINJ1, the executioner of membrane rupture during cell death. In glucose-starved macrophages, NINJ1 ruptures membranes independently of known cell death programs. Consistently, NINJ1 is the dominant effector of fungal-induced macrophage damage amongst host cell death factors. Supplementation of the amino acid alanine rescues glucose-starved macrophages better than glucose, and it does so by inhibiting NINJ1 oligomerization. Moreover, C. albicans infection disrupts amino acid metabolism in mice and reduces serum alanine. Finally, NINJ1-mediated membrane rupture enables C. albicans egress from macrophages together with the toxin candidalysin. We establish the mechanism of glucose starvation-induced macrophage damage by NINJ1, and demonstrate the roles of NINJ1 and alanine in immune responses to Candida and fungal escape. Introduction Infection with fungal, bacterial, parasitic and viral pathogens changes glucose homeostasis in the host1–9. Consequently, regulation of glucose metabolism is important for host survival of infection1–9. An important aspect of glucose metabolism is the requirement for glycolysis in promoting antimicrobial responses by macrophages. Upon detection of microbes, macrophages adapt their metabolic pathways, with enhanced glycolysis being a defining feature1,8,10–16. Due to enhanced glycolysis, infected macrophages have an increased need for glucose, both as an energy source and for mounting antimicrobial responses, including production of antimicrobial cytokines, reactive oxygen species (ROS) and phagosome acidification1,6,8,11,12,17–21. However, the demand for glucose can pose a challenge for macrophages because several pathogens are avid glucose consumers, leading to glucose-depleted conditions within infection microenvironments1,2,22–26. Moreover, pathogens can disrupt glucose metabolism in macrophages with immunological consequences. We have shown that Candida albicans and Candida auris, two fungal pathogens categorised as “critical priority” by the World Health Organization, deplete glucose and cause glucose starvation in macrophages that culminates in widespread immune cell death1,24. Similarly, disruption of macrophage glycolysis has been reported after infection with bacterial pathogens such as Salmonella typhimurium and Yersinia pseudotuberculosis, as well as upon challenge with peptidoglycan2,20,23,27. Additionally, Staphylococcus aureus causes glucose stress in keratinocytes during skin infections25. Given its importance, modulating glucose homeostasis holds promise for promoting protective immune response and improving disease outcomes. However, the mechanisms that enable macrophages to respond to glucose starvation by inducing immune cell death and inflammation are incompletely defined. We have recently demonstrated that glucose-starved macrophages infected with C. albicans or C. auris undergo lytic cell death1,24. Lytic cell death could reduce the containment of fungi and promote dissemination, since Candida species proliferate in extracellular environments using a range of host nutrients. However, glucose starvation and macrophage lysis also promote macrophage antifungal inflammation dependent on the NLRP3 inflammasome28. Collectively, these findings suggest a role for glucose homeostasis in balancing Candida containment by macrophages and activation of immune responses to clear infections. Despite this important role, the mechanism linking metabolic dysfunction with macrophage lysis remains unclear. Although glucose-starved macrophages activate the NLRP3 inflammasome in response to C. albicans28, and an activated NLRP3 inflammasome causes lytic macrophage pyroptosis under many conditions29, NLRP3 was surprisingly dispensable for macrophage lysis following C. albicans-induced glucose starvation despite inducing the secretion of the antifungal cytokine IL-1ß28. NLRP3 was also dispensable for macrophage lysis upon glucose starvation caused by C. auris24. Apoptosis or excessive accumulation of reactive oxygen species (ROS) kill glucose-starved cancer cells30–32, but these mechanisms do not account for the lysis of glucose-starved macrophages upon C. albicans and/or C. auris infection1,24,28. In this study, we employed a metabolite supplementation approach to discover the mechanism of cell lysis in glucose-starved macrophages responding to fungal pathogens. We show that the amino acid alanine strongly improves macrophage integrity following infection with three Candida species, C. albicans, C. auris and C. glabrata. Alanine improved membrane integrity of glucose-starved macrophages better than supplementation of glucose, but independently of its metabolic utilisation. Using alanine as a tool, we demonstrate that infection-induced glucose starvation triggers membrane damage that depends on NINJ1, the recently identified factor that induces plasma membrane rupture (PMR) and cell lysis upon immune cell death33. We show that NINJ1 operates independently of major cell death programs in response to glucose starvation caused by C. albicans, and demonstrate that alanine reduces macrophage membrane damage during C. albicans challenge by inhibiting NINJ1. Our analyses of cell death pathways established that NINJ1 has the most dominant role in mediating C. albicans-induced macrophage damage and is the only cell death factor identified so far that ruptures macrophages infected by C. auris. Finally, we show a key role for NINJ1-induced macrophage PMR and its inhibition by alanine in controlling fungal egress from macrophages, and provide evidence of the roles of NINJ1 and alanine in antifungal immune responses. Results Alanine rescues macrophages from cell damage caused by glucose starvation In infected animals, C. albicans causes a lowering of blood glucose levels, in addition to depleting available glucose for macrophages1,34. Supplementing glucose rescues C. albicans-infected macrophages by promoting their viability and cellular integrity, but it also potently promotes fungal growth and thus provides an advantage to C. albicans1. We therefore considered whether metabolite rescue of macrophages without advantaging C. albicans is feasible. Amino acid metabolism may be a possible avenue to achieve this goal, since amino acids can support macrophage immunometabolism35–37. Furthermore, while C. albicans grows on amino acids, they are not its preferred carbon source. The effects of fungal infection on global host amino acid homeostasis are poorly understood. We found that mice systemically infected with C. albicans display perturbed amino acid homeostasis. There was a reduction in serum levels for arginine, aspartate, serine, glycine, alanine and several other amino acids (Figs. 1A, and S1). In contrast, glutamine, glutamate and others remained unchanged, while the levels of valine increased upon infection (Figs. 1A, and S1). It is likely that alterations to systemic, immune cell and pathogen metabolism are collectively contributing to broadly changed amino acid homeostasis in infected animals. We have previously shown that supplementation of arginine, serine, glutamine or leucine has no or very minor effects on rescuing C. albicans-infected macrophages1. Proline and isoleucine also had no effect (Fig. S2). Alanine is an important metabolic substrate in mammals, both as a gluconeogenic substrate and feeding into the Krebs cycle for ATP production. Alanine metabolism plays a role in low nutrient conditions and under metabolic stress38, and there was a 2-fold reduction in serum levels in C. albicans-infected mice (Fig. 1A). Therfeore, we tested its effects on C. albicans-infected macrophages.Fig. 1Alanine rescues macrophages from membrane damage caused by glucose starvation.A Schematic of mouse infections with C. albicans for serum collection and a radar plot of serum amino acid levels in C. albicans-infected vs mock-infected mice. Amino acids are labeled in the 3-letter code. Plotted are the log2FC (fold change) relative to mock-infected animals. Quantitative data for alanine is shown in the graph (means and SEM for n = 7 mice in the uninfected condition and n = 9 mice in the Candida-infected condition). Statistical comparisons between uninfected and infected mice were done using the two tailed students t-test, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Fig. S1 shows quantification of all the indicated amino acids, and exact p values are shown in the Source data file. B Macrophages (BMDMs) were challenged with C. albicans (strain SC5314, MOI 3) in base medium with 10 mM glucose (blue graph) or with supplementation of additional glucose or alanine as indicated. Membrane permeabilization was quantified as DRAQ7-positive nuclei. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. C TEM images of macrophages (BMDMs) infected with C. albicans in the presence or absence of alanine. The MOI was 3, and samples were taken at 12 h p.i. Representative magnifications are indicated by perforated boxes. Membrane integrity or rupture is shown in the magnified images, and fungal hyphae are indicated by blue arrowheads. Images were acquired at 1200 magnification with scale bars of 5 μm. Magnifications were acquired at either 3000X or 10000X with scale bars of 2 μm or 500 nm, respectively. D LDH release at 3, 14 and 16 h post BMDM challenge with C. albicans. Shown are means and SEM from four independent experiments (2-way ANOVA, Tukey’s multiple comparison test, ** p ≤ 0.01). E ATP levels in C. albicans-infected BMDMs at 3 and 14 h post-infection in the presence or absence of alanine. Shown are means and SEM from three independent experiments. (2-way ANOVA Tukey’s multiple comparison test) F IL-1ß ELISA with and without 10 mM L-alanine. Following priming with 50 ng/ml LPS for 3 h, BMDMs were challenged with C. albicans and samples taken at the indicated time points. Shown are means and SEM for four independent experiments (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05).G BMDMs were challenged with C. albicans SC5314 at MOI 1 or 6. Shown are means and SEM for three independent experiments. At least 3500 macrophages were imaged in each experiment per experimental group. H As in B, but infection with the indicated C. albicans isolates (MOI 3). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. I As in B, but with human monocyte-derived macrophages (hMDMs). Shown are means and SEM for 2 independent donors. At least 1400 macrophages were quantified per experiment, for each experimental group. J As in (B), but BMDMs were challenged with C. auris (MOI 6). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. K As in B, but BMDMs were challenged with C. glabrata (MOI 10). Shown are the means and SEM from three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. Alanine rescues macrophages from membrane damage caused by glucose starvation. A Schematic of mouse infections with C. albicans for serum collection and a radar plot of serum amino acid levels in C. albicans-infected vs mock-infected mice. Amino acids are labeled in the 3-letter code. Plotted are the log2FC (fold change) relative to mock-infected animals. Quantitative data for alanine is shown in the graph (means and SEM for n = 7 mice in the uninfected condition and n = 9 mice in the Candida-infected condition). Statistical comparisons between uninfected and infected mice were done using the two tailed students t-test, * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001. Fig. S1 shows quantification of all the indicated amino acids, and exact p values are shown in the Source data file. B Macrophages (BMDMs) were challenged with C. albicans (strain SC5314, MOI 3) in base medium with 10 mM glucose (blue graph) or with supplementation of additional glucose or alanine as indicated. Membrane permeabilization was quantified as DRAQ7-positive nuclei. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. C TEM images of macrophages (BMDMs) infected with C. albicans in the presence or absence of alanine. The MOI was 3, and samples were taken at 12 h p.i. Representative magnifications are indicated by perforated boxes. Membrane integrity or rupture is shown in the magnified images, and fungal hyphae are indicated by blue arrowheads. Images were acquired at 1200 magnification with scale bars of 5 μm. Magnifications were acquired at either 3000X or 10000X with scale bars of 2 μm or 500 nm, respectively. D LDH release at 3, 14 and 16 h post BMDM challenge with C. albicans. Shown are means and SEM from four independent experiments (2-way ANOVA, Tukey’s multiple comparison test, ** p ≤ 0.01). E ATP levels in C. albicans-infected BMDMs at 3 and 14 h post-infection in the presence or absence of alanine. Shown are means and SEM from three independent experiments. (2-way ANOVA Tukey’s multiple comparison test) F IL-1ß ELISA with and without 10 mM L-alanine. Following priming with 50 ng/ml LPS for 3 h, BMDMs were challenged with C. albicans and samples taken at the indicated time points. Shown are means and SEM for four independent experiments (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05).G BMDMs were challenged with C. albicans SC5314 at MOI 1 or 6. Shown are means and SEM for three independent experiments. At least 3500 macrophages were imaged in each experiment per experimental group. H As in B, but infection with the indicated C. albicans isolates (MOI 3). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. I As in B, but with human monocyte-derived macrophages (hMDMs). Shown are means and SEM for 2 independent donors. At least 1400 macrophages were quantified per experiment, for each experimental group. J As in (B), but BMDMs were challenged with C. auris (MOI 6). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. K As in B, but BMDMs were challenged with C. glabrata (MOI 10). Shown are the means and SEM from three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. To do so, we utilized our live-cell imaging platform with bone marrow-derived mouse macrophages (BMDMs)1. Here, macrophage plasma membrane permeabilization is quantified over time using the membrane-impermeable DNA-binding dye DRAQ7. In this assay, C. albicans depletes glucose, resulting in glucose starvation of macrophages and cell death several hours after infection1 and (Fig. 1B). Supplementation of alanine rescued macrophages from glucose starvation-induced plasma membrane permeabilization, and the rescue was more potent than supplementation of glucose at the same concentrations (Fig. 1B). C. albicans growth was the same in the presence or absence of alanine (Fig. S3A), showing that alanine rescued macrophages without providing an advantage to C. albicans. Moreover, hyphal growth, which contributes to macrophage damage, was also unaffected by alanine, either during macrophage interactions (Fig. S3B) or in vitro in macrophage infection medium (Fig. S3C). In addition to reducing macrophage membrane permeabilization (measured by DRAQ7-staining, Fig. 1B), alanine also reduced C. albicans-induced PMR and macrophage lysis, as shown by transmission electron microscopy (TEM) (Fig. 1C) and reduced lactate dehydrogenase (LDH) release (Fig. 1D). In contrast, the reduction of ATP levels due to cell death was not inhibited by alanine (Fig. 1E). Thus, alanine preserves membrane integrity but does not reduce macrophage cell death caused by C. albicans. We next tested if alanine could impact macrophage effector functions against C. albicans. Alanine had no effect on C. albicans phagocytosis (Fig. S3D) and no effect on fungal growth inhibition by macrophages (Fig. S3E). In contrast, alanine caused a reduction in secreted pro-inflammatory cytokine IL-1ß at 3 and 14 h post-infection (Fig. 1F). At 16 h after infection, alanine had no effect on IL-1ß secretion, which was high in the presence or absence of alanine (Fig. 1F). Next, we tested several multiplicities of infection (i.e., the ratio of C. albicans to macrophages), which can influence the kinetics of macrophage cell death and glucose starvation1,28. We also tested additional C. albicans clinical isolates showing distinct abilities to damage macrophages28,39. Alanine rescued macrophages infected at both high (6:1) and low (1:1) multiplicity of infection (Fig. 1G). In addition to the prototype isolate SC5314 (Fig. 1A), alanine rescued macrophages during infection with other C. albicans isolates (Fig. 1H). Rescue by alanine was recapitulated in primary monocyte-derived human macrophages (Fig. 1I). Finally, alanine also rescued macrophages from damage caused by two other Candida sp fungal pathogens: C. auris and C. glabrata (Fig. 1J, K). Collectively, these results show that alanine rescues macrophages infected with three different fungal pathogens, in response to multiple clinical isolates, and the rescue is recapitulated in mouse and human immune cells. Macrophage rescue does not require metabolic utilization of alanine Alanine rescued C. albicans-infected macrophages better than glucose (Fig. 1B). This finding prompted us to consider whether the rescue may be non-metabolic. To test this, we used L- and D-isomers of alanine. L-alanine is metabolized effectively by fungal and mammalian cells (and was used in our experiments so far). D-alanine is not metabolized well. Yet, D-alanine rescued C. albicans-infected macrophages as well as L-alanine (Fig. 2A), without affecting the growth or filamentation of C. albicans (Figs. 2B and S3A, C).Fig. 2Alanine rescues macrophages independently of its metabolism.A Macrophage membrane permeabilization during C. albicans infection (strain SC5314, BMDMs) in base medium (blue) or with supplementation of 10 mM L- or D-alanine. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment for each of the experimental groups. B Images of C. albicans hyphae during infections of BMDMs, with or without 10 mM L- or D-alanine. Images were taken 8 h post-infection. Scale bar=50 µm. C Macrophages (BMDMs) infected with wild type C. albicans, alt1Δ/Δ and the complemented strain alt1Δ/Δ + ALT1 (MOI 1), with or without 10 mM L-alanine. Membrane permeabilization was quantified using DRAQ7. Shown are means and SEM from three independent experiments. At least 3000 macrophages were imaged per experiment and each experimental group. D As in (C) but in the presence or absence of D-alanine. Shown are the means and SEM for three independent experiments. At least 2500 macrophages were quantified per experiment for each of the experimental groups. E Images showing mitochondrial hyperpolarisation (TMRM staining) and permeabilised macrophages (DRAQ7 staining) after 11 h of C. albicans infection. Supplementation of L-alanine does not delay mitochondrial hyperpolarisation, although it delays membrane permeabilization. In contrast, glucose delays both. Images are from experiments in panel F, which shows quantification of the TMRM and DRAQ7 data. Scale bar= 50 µm. F Left panel: quantification of C. albicans-infected BMDMs displaying hyperpolarized mitochondria using TMRM fluorescence. Base medium was supplemented with glucose or L-alanine as indicated. Right panel: macrophage membrane permeabilization from the same experiments quantified using DRAQ7 staining. Shown are means and SEM from three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. Alanine rescues macrophages independently of its metabolism. A Macrophage membrane permeabilization during C. albicans infection (strain SC5314, BMDMs) in base medium (blue) or with supplementation of 10 mM L- or D-alanine. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment for each of the experimental groups. B Images of C. albicans hyphae during infections of BMDMs, with or without 10 mM L- or D-alanine. Images were taken 8 h post-infection. Scale bar=50 µm. C Macrophages (BMDMs) infected with wild type C. albicans, alt1Δ/Δ and the complemented strain alt1Δ/Δ + ALT1 (MOI 1), with or without 10 mM L-alanine. Membrane permeabilization was quantified using DRAQ7. Shown are means and SEM from three independent experiments. At least 3000 macrophages were imaged per experiment and each experimental group. D As in (C) but in the presence or absence of D-alanine. Shown are the means and SEM for three independent experiments. At least 2500 macrophages were quantified per experiment for each of the experimental groups. E Images showing mitochondrial hyperpolarisation (TMRM staining) and permeabilised macrophages (DRAQ7 staining) after 11 h of C. albicans infection. Supplementation of L-alanine does not delay mitochondrial hyperpolarisation, although it delays membrane permeabilization. In contrast, glucose delays both. Images are from experiments in panel F, which shows quantification of the TMRM and DRAQ7 data. Scale bar= 50 µm. F Left panel: quantification of C. albicans-infected BMDMs displaying hyperpolarized mitochondria using TMRM fluorescence. Base medium was supplemented with glucose or L-alanine as indicated. Right panel: macrophage membrane permeabilization from the same experiments quantified using DRAQ7 staining. Shown are means and SEM from three independent experiments. At least 3000 macrophages were quantified per experiment and each experimental group. To further understand the impact of alanine metabolism, we generated a C. albicans alt1Δ/Δ mutant that lacks alanine aminotransferase needed for alanine utilization. The alt1Δ/Δ mutant grew normally in macrophage culture medium in the presence or absence of alanine (Fig. S3A), formed hyphae in vitro and within macrophages (Fig. S3C, F), and was phagocytosed by macrophages normally (Fig. S3G). Moreover, under standard conditions (no additional alanine), the alt1Δ/Δ mutant triggered macrophage plasma membrane permeabilization with the same kinetics as the parental strain (Fig. 2C). However, in the presence of L-alanine, infections with alt1Δ/Δ led to prolonged rescue relative to the parental C. albicans strain (Fig. 2C, compare red and orange graphs). The delayed macrophage rescue by alanine was partially reversed by complementation with ALT1 (Fig. 2C, orange versus yellow graphs). Consistent with D-alanine not being metabolised, infection with the alt1Δ/Δ mutant did not lead to prolonged rescue in the presence of D-alanine (Fig. 2D). D-alanine did not have any effects on the growth or filamentation of the alt1Δ/Δ mutant (Fig. S3A, C). Collectively, these results show that C. albicans metabolises L-alanine and competes for it with macrophages. Furthermore, the data with D-alanine and the alt1Δ/Δ mutant provide further evidence that macrophage rescue is independent of alanine’s metabolism. To further test the role of metabolism, we turned to our previous discovery showing that C. albicans-induced glucose starvation triggers a hyperpolarization event in macrophage mitochondria, followed by depolarization1. These changes in mitochondrial membrane potential result from metabolic dysfunction and can be delayed by glucose supplementation1. Unlike glucose, supplementation of alanine did not delay mitochondrial hyperpolarization/depolarization, despite delaying macrophage plasma membrane permeabilization (Fig. 2E, F). Thus, alanine does not correct the metabolic dysfunction caused by glucose starvation. Instead, it acts downstream of metabolic dysfunction to prevent macrophage plasma membrane damage. Alanine does not act on pyroptosis, necroptosis or apoptosis Next, we tested for a potential involvement of immune cell death programs, since C. albicans triggers NLRP3-caspase-1 inflammasome-dependent pyroptosis in the first few hours post infection40,41. In pyroptosis-negative Gsdmd–/– macrophages (lacking the pore-forming protein Gasdermin D) the initial membrane permeabilization was delayed as expected, but alanine caused a further delay showing that it does not need GSDMD to rescue macrophages (Fig. 3A). Similarly, alanine rescued C. albicans-infected Nlrp3–/– macrophages (Fig. 3B). Of note, we have previously shown that in C. albicans-infected macrophages GSDMD processing to its pore-forming fragment depends on NLRP3; however, in our imaging assay, Nlrp3–/– macrophages show a reduced initial delay in DRAQ7-positive macrophages relative to Gsdmd–/– due to increased formation of macrophage extracellular nets that are also stained by DRAQ742.Fig. 3Alanine rescues macrophages independently of pyroptosis, necroptosis and apoptosis.A Wild type (WT) or Gsdmd–/– BMDMs challenged with C. albicans SC5314 (MOI 6) with or without supplementation of 10 mM L-alanine. DRAQ7-positive macrophages were quantified using live-cell imaging. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. B As in (A) but wild type (WT) and Nlrp3–/– BMDMs (MOI 3). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. C Immunoblots from C. albicans-infected BMDMs with or without 10 mM L-alanine. Samples were pre-treated with 50 ng/ml LPS. Active, proteolytically processed fragments are p17 for IL-1β, p20 for caspase-1 and p30 for GSDMD. A representative of three independent experiments is shown. Uncropped blots are shown in Fig. S4A. D BMDMs were treated with the pan-apoptotic caspase inhibitor QVD (10 μM) and 10 mM L-alanine. Shown are means and SEM for three independent experiments. At least 3500 macrophages were quantified per experiment and experimental group. E As in (A), but wild type and Mlkl–/– immortalized BMDMs (iBMDMs) were compared. Shown are the means and SEM for three independent experiments. At least 2500 macrophages were quantified per experiment and experimental group. F As in (E) comparing wild type (WT) or mutant iBMDMs lacking Casp1, Casp4, Casp12, Casp8 and Ripk3. Shown are means and SEM for three independent experiments. At least 3500 macrophages were quantified per experiment and experimental group. Alanine rescues macrophages independently of pyroptosis, necroptosis and apoptosis. A Wild type (WT) or Gsdmd–/– BMDMs challenged with C. albicans SC5314 (MOI 6) with or without supplementation of 10 mM L-alanine. DRAQ7-positive macrophages were quantified using live-cell imaging. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. B As in (A) but wild type (WT) and Nlrp3–/– BMDMs (MOI 3). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. C Immunoblots from C. albicans-infected BMDMs with or without 10 mM L-alanine. Samples were pre-treated with 50 ng/ml LPS. Active, proteolytically processed fragments are p17 for IL-1β, p20 for caspase-1 and p30 for GSDMD. A representative of three independent experiments is shown. Uncropped blots are shown in Fig. S4A. D BMDMs were treated with the pan-apoptotic caspase inhibitor QVD (10 μM) and 10 mM L-alanine. Shown are means and SEM for three independent experiments. At least 3500 macrophages were quantified per experiment and experimental group. E As in (A), but wild type and Mlkl–/– immortalized BMDMs (iBMDMs) were compared. Shown are the means and SEM for three independent experiments. At least 2500 macrophages were quantified per experiment and experimental group. F As in (E) comparing wild type (WT) or mutant iBMDMs lacking Casp1, Casp4, Casp12, Casp8 and Ripk3. Shown are means and SEM for three independent experiments. At least 3500 macrophages were quantified per experiment and experimental group. Consistent with the effect of alanine being independent of inflammasome-induced cell lysis, supplementation of alanine did not prevent the processing of caspase 1, IL-1ß or GSDMD in response to C. albicans, although it reduced their release into the supernatant due to reduced plasma membrane rupture (Fig. 3C, uncropped blots shown in Fig. S4A). Alanine also rescued macrophages when all apoptotic caspase-dependent pathways were chemically inhibited with Q-VD-OPh (QVD) (Fig. 3D). Furthermore, alanine rescued necroptosis-negative Mlkl–/– macrophages (Fig. 3E), as well as macrophages in which pyroptosis, necroptosis and extrinsic apoptosis were simultaneously disrupted using genetic approaches43 (Fig. 3F). NINJ1 is the target of Alanine’s rescue and the effector of glucose starvation-induced macrophage plasma membrane damage To investigate other cell death factors potentially involved in alanine’s rescue, we re-analyzed our published RNAseq dataset from C. albicans-infected BMDMs1. Five genes encoding cell death factors showed increased expression upon C. albicans infection: Nlrp3 and Casp11 (pyroptosis), Mlkl (necroptosis), Zbp1 (apoptosis and necroptosis) and Ninj1 (performs macrophage plasma membrane rupture (PMR) downstream of several immune cell death pathways) (Fig. 4A). We ruled out pyroptosis and necroptosis in mediating the lysis of glucose-starved macrophages and being involved in macrophage rescue by alanine (Fig. 3). Zbp1 is also unlikely because it signals for caspase-8-driven apoptosis and MLKL-mediated necroptosis44, which we excluded (Fig. 3). We thus focused on the recently identified executioner of PMR, NINJ133. Indeed, we show that Ninj1 expression is upregulated by C. albicans infection not only in mouse macrophages (Fig. 4A), but also in human macrophages (Figs. 4B and S5A). While transcript levels were increased, NINJ1 protein levels did not change over the course of C. albicans challenge (Fig. S4B, C).Fig. 4NINJ1 drives membrane damage of glucose-starved macrophages and is required for alanine’s rescue.A Heatmap of differential gene expression in C. albicans-infected vs uninfected macrophages. Shown is log2 fold change, FDR < 0.05. Data is from our published manuscript1, and is accessible at http://rnasystems.erc.monash.edu/2017/papers/glucose_comp/. On the right we show Ninj1 expression (average of the normalized counts) in infected and uninfected macrophages over time. B Quantitative PCR of Ninj1 expression normalized to actin (Actb), in C. albicans-infected tdBLaER1 human macrophage-like cell line. Shown are means and SEM for three independent experiments, two technical replicates each (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05). Data for activation of NINJ1 expression in human monocyte-derived macrophages (hMDMs) is shown in Fig S5A. C Wild type (WT) and Ninj1–/– BMDMs infected with C. albicans at MOI 6 in base medium (dark and light blue curves) or with supplementation of 10 mM L-alanine (red and orange curves). Membrane permeabilization was quantified using DRAQ7. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. D LDH release from C. albicans-infected control or Ninj1–/– iBMDMs at 14 h post infection, relative to Triton X-lysed macrophages. Shown are means and SEM from four independent experiments (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05, **** p ≤ 0.0001) E As in (D), but wild type (WT) and Ninj1–/– BMDMs challenged with C. auris (MOI 6). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. F Crosslinking-Western blot experiments to analyse the formation of NINJ1 oligomers in nigericin-treated macrophages +/− 10 mM L-alanine. Glycine at 10 mM was used as a control NINJ1 antagonist. A representative of three experiments is shown. Uncropped actin Western blots are shown in Fig S4D. A similar result was obtained with Blue-Native (BN)-PAGE in Fig S7A. G As in D but with 10 mM glycine. Shown are means and SEM for three independent experiments. Infections here and in panel D were performed within the same experiments, and therefore, the control data (WT and Ninj1–/– macrophages without supplements) is the same as in (D). At least 3000 macrophages were quantified per experiment and experimental group. H IL-1β ELISA from control and Ninj1–/– iBMDMs upon challenge with C. albicans +/− 10 mM L-alanine. Triton-X and uninfected macrophages were the positive and negative control respectively. Shown are means and SEM for four independent experiments (2-way ANOVA Tukey’s multiple comparison test, ** p ≤ 0.01, *** p ≤ 0.001). I IL-1β ELISA from control (WT) and Ninj1–/– primary BMDMs upon challenge with C. albicans +/− 10 mM L-alanine. Triton-X and uninfected macrophages were the positive and negative controls, respectively. Shown are means and SEM for four independent experiments (statistical significance between WT and Ninj1–/– BMDMs was tested using a 2-way ANOVA Tukey’s multiple comparison test). J Immunoblot for IL-1ß (p17), caspase-1 (p20), GSDMD (p30) processing from C. albicans infected wild type (WT) and Ninj1–/– BMDMs +/− 10 mM L-alanine or glycine, 16 h post-infection. All samples were pre-treated with 50 ng/ml LPS. Representative of three experiments is shown. Uncropped blots are shown in Fig. S4E. NINJ1 drives membrane damage of glucose-starved macrophages and is required for alanine’s rescue. A Heatmap of differential gene expression in C. albicans-infected vs uninfected macrophages. Shown is log2 fold change, FDR < 0.05. Data is from our published manuscript1, and is accessible at http://rnasystems.erc.monash.edu/2017/papers/glucose_comp/. On the right we show Ninj1 expression (average of the normalized counts) in infected and uninfected macrophages over time. B Quantitative PCR of Ninj1 expression normalized to actin (Actb), in C. albicans-infected tdBLaER1 human macrophage-like cell line. Shown are means and SEM for three independent experiments, two technical replicates each (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05). Data for activation of NINJ1 expression in human monocyte-derived macrophages (hMDMs) is shown in Fig S5A. C Wild type (WT) and Ninj1–/– BMDMs infected with C. albicans at MOI 6 in base medium (dark and light blue curves) or with supplementation of 10 mM L-alanine (red and orange curves). Membrane permeabilization was quantified using DRAQ7. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. D LDH release from C. albicans-infected control or Ninj1–/– iBMDMs at 14 h post infection, relative to Triton X-lysed macrophages. Shown are means and SEM from four independent experiments (2-way ANOVA Tukey’s multiple comparison test, * p ≤ 0.05, **** p ≤ 0.0001) E As in (D), but wild type (WT) and Ninj1–/– BMDMs challenged with C. auris (MOI 6). Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment and experimental group. F Crosslinking-Western blot experiments to analyse the formation of NINJ1 oligomers in nigericin-treated macrophages +/− 10 mM L-alanine. Glycine at 10 mM was used as a control NINJ1 antagonist. A representative of three experiments is shown. Uncropped actin Western blots are shown in Fig S4D. A similar result was obtained with Blue-Native (BN)-PAGE in Fig S7A. G As in D but with 10 mM glycine. Shown are means and SEM for three independent experiments. Infections here and in panel D were performed within the same experiments, and therefore, the control data (WT and Ninj1–/– macrophages without supplements) is the same as in (D). At least 3000 macrophages were quantified per experiment and experimental group. H IL-1β ELISA from control and Ninj1–/– iBMDMs upon challenge with C. albicans +/− 10 mM L-alanine. Triton-X and uninfected macrophages were the positive and negative control respectively. Shown are means and SEM for four independent experiments (2-way ANOVA Tukey’s multiple comparison test, ** p ≤ 0.01, *** p ≤ 0.001). I IL-1β ELISA from control (WT) and Ninj1–/– primary BMDMs upon challenge with C. albicans +/− 10 mM L-alanine. Triton-X and uninfected macrophages were the positive and negative controls, respectively. Shown are means and SEM for four independent experiments (statistical significance between WT and Ninj1–/– BMDMs was tested using a 2-way ANOVA Tukey’s multiple comparison test). J Immunoblot for IL-1ß (p17), caspase-1 (p20), GSDMD (p30) processing from C. albicans infected wild type (WT) and Ninj1–/– BMDMs +/− 10 mM L-alanine or glycine, 16 h post-infection. All samples were pre-treated with 50 ng/ml LPS. Representative of three experiments is shown. Uncropped blots are shown in Fig. S4E. Deletion of Ninj1 rescued C. albicans-infected macrophages from damage caused by glucose starvation, inhibiting both plasma membrane permeabilization (DRAQ7-staining, Fig. 4C and Movie S1) and PMR (LDH release, Fig. 4D). Ninj1 loss conferred the strongest rescue of C. albicans-infected macrophages when compared with other host cell death factors that we have tested (compare Fig. 4C with data in Fig. 3 and our previous work1,28,40,45). The C. albicans tye7Δ/Δ gal4Δ/Δ mutant is slower in consuming glucose and therefore slower in causing glucose starvation-dependent macrophage lysis1. In wild-type macrophages, the tye7Δ/Δ gal4Δ/Δ was ~4 h slower in triggering macrophage membrane damage, while in Ninj1–/– macrophages the delay was reduced to ~1 h (Fig. S5B). This is consistent with NINJ1 being the main driver of glucose starvation-dependent macrophage lysis. The intraperitoneal mouse model of C. albicans infection was used to test the role of NINJ1 in vivo. Relative to wild-type animals, deletion of Ninj1 caused a trend towards higher spleen weight and fungal load 24 h following infection, albeit with a comparable weight loss (Fig. S6A–D). However, these differences did not achieve statistical significance. There was no difference between wild-type and Ninj1–/– animals in kidney weight or fungal load (Fig. S6C–E). To explore potential organ-specific effects, we compared fungal burdens between the spleen and kidney within each genotype. This showed that Ninj1–/–, but not wild type animals, showed statistically significantly higher fungal load in spleen compared to kidneys (Fig. S6F). In another C. albicans infection model (intravenous injection), fungal growth is better controlled in the spleen than in the kidneys due to larger numbers of innate immune phagocytes and inhibition of invasive fungal filamentation46. Our data suggest that NINJ1-mediated PMR may contribute to controlling C. albicans proliferation in the spleen in the intraperitoneal infection model. Confirming its broad role in response to fungi, deletion of Ninj1 also reduced membrane damage in macrophages infected with C. auris (Fig. 4E). Alanine did not further rescue Ninj1–/– macrophages (neither membrane permeabilization nor PMR) (Fig. 4C, D), showing that alanine needs NINJ1 to exert its protective effects. NINJ1 oligomerizes in the membrane as a prerequisite for PMR33,47. Consistent with a previous report48, alanine reduced NINJ1 oligomerisation as seen in cross-linking and BN-PAGE experiments (Figs. 4F and S7A). Collectively, these results show that alanine rescues glucose-starved macrophages by inhibiting NINJ1. Glycine, an amino acid that is structurally similar to alanine, is reported to inhibit PMR by preventing NINJ1 oligomerization48. We could recapitulate this effect in our experiments (Figs. 4F and S7A). Therefore, to further test the involvement of NINJ1 in glucose starvation and fungal infections, we asked if glycine acts similarly to alanine in rescuing glucose-starved macrophages via NINJ1. Indeed, glycine rescued C. albicans-infected macrophages in a NINJ1-dependent manner by reducing both membrane permeabilization (DRAQ7 staining, Fig. 4G) and PMR (LDH release, Fig. 4D). Since NINJ1 ruptures macrophages during pyroptosis33, this result explains how glycine inhibits C. albicans-induced pyroptosis41. However, NINJ1 has an additional role in response to glucose starvation, since glycine rescued Gsdmd–/– macrophages, both mouse (Fig. S8A) and human (Fig. S8B). This is consistent with no role for GSDMD-dependent pyroptosis in response to NINJ1-dependent membrane damage caused by glucose stress. IL-1ß secretion was reduced in C. albicans-infected Ninj1–/– immortalised macrophages (iBMDMs), with no further reduction upon supplementation with alanine or glycine (Fig. 4H). However, no reduction in IL-1ß secretion was seen in C. albicans-infected primary Ninj1–/– BMDMs (Fig. 4I), although alanine caused lower IL-1ß secretion in primary BMDMs (Fig. 1F). Proteolysis of IL-1ß was normal in Ninj1–/– macrophages, suggesting that inflammasome signaling is normal (Fig. 4J). Similarly, caspase-1 and GSDMD were proteolytically processed in C. albicans-infected Ninj1–/– macrophages, although less cleaved GSDMD was found in supernatants consistent with reduced PMR (Fig. 4J). NINJ1 is a macrophage escape factor for C. albicans working together with candidalysin Inactivation of NINJ1 caused a large reduction in membrane permeabilization following C. albicans infection, but the rescue was not complete (Fig. 4D). We therefore decided to determine the mechanism causing the additional damage. The fungal pore-forming peptide candidalysin is secreted at high levels by C. albicans hyphae49, whereby it damages the macrophage plasma membrane during hyphal escape42,50,51. Therefore, candidalysin was a candidate factor causing the residual membrane damage in the absence of NINJ1. Following infection with a mutant lacking the candidalysin-encoding gene ECE1 (ece1Δ/Δ), there was an initial delay in macrophage plasma membrane permeabilization (Fig. 5A). This is consistent with the roles of candidalysin in hyphal escape42,51. Compared to wild-type C. albicans, infection with ece1Δ/Δ further reduced plasma membrane permeabilization in Ninj1–/– macrophages (Fig. 5A). The additional effect of candidalysin was also seen in human macrophages when NINJ1 was inactivated by glycine (Figs. 5B and S5C). These data show that candidalysin is responsible for the residual damage in the absence of NINJ1 in mouse and human macrophages. We further show that C. albicans infection causes NINJ1 oligomerization, which was reduced in infections with ece1Δ/Δ (Figs. 5C and S7B). Therefore, in addition to working in parallel to NINJ1-dependent pathways, candidalysin-induced membrane damage also contributes to activation of NINJ1 following C. albicans infection.Fig. 5NINJ1-dependent membrane damage in conjunction with candidalysin causes macrophage escape of C. albicans.A Control Ninj1+/+ and Ninj1–/– iBMDMs were infected with wild-type C. albicans (BWP17) and the isogenic candidalysin mutant ece1Δ/Δ (MOI 3). Macrophage plasma membrane permeabilization was quantified by DRAQ7 in live-cell imaging. Shown are means and SEM from three independent replicates. At least 3500 macrophages were quantified per experiment, for each experimental group. B LDH release from hMDMs infected with C. albicans wild type (WT) or ece1Δ/Δ at 24 h. NINJ1 was inhibited with 50 mM glycine. Shown are means and SEM from four independent donors (two-tailed t-test with Welch’s correction * p ≤ 0.05) C Crosslinking-Western blot experiments showing oligomerised NINJ1 in BMDMs following infection with wild type (WT) or ece1Δ/Δ C. albicans. Another independent repeat of this experiment using BN-PAGE is shown in Fig S7B. Unprocessed blots for actin are shown in Fig. S4D. D Control Ninj1+/+and Ninj1–/– iBMDMs challenged with the indicated C. albicans isolates and imaged to quantify DRAQ7-positive macrophages (MOI 3). The hyphal index (h.i., calculated from hyphal length divided by width) within macrophages is indicated on each graph28. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment, for each experimental group. E Time-lapse images of C. albicans strain P78042 escaping from control Ninj1+/+ or Ninj1–/– iBMDMs. The white dashed line demarcates intact macrophages containing C. albicans. Yellow arrows indicate escaped hyphae and their extracellular growth over time. The DRAQ7 signal (indicating permeabilized macrophages) is overlayed in red. Scale bar=100 µm. Shown are representative images from three independent replicates. See also Movie S2. F Confocal imaging of escaped C. albicans (strain P78042), stained with the fungal cell wall dye calcofluor white (blue). Calcofluor white differentially labels escaped fungi42. Control Ninj1+/+ or Ninj1–/– iBMDMs were stained with phalloidin (red). Images were taken at 8 h post-infection. Scale bar=100 µm. G Quantification of escaped C. albicans based on fluorescence (see Materials and Methods). An example of full field images used for the quantification are shown in Fig S9A. Shown are means and SEM from three independent experiments (two tailed t-test * p ≤ 0.05). NINJ1-dependent membrane damage in conjunction with candidalysin causes macrophage escape of C. albicans. A Control Ninj1+/+ and Ninj1–/– iBMDMs were infected with wild-type C. albicans (BWP17) and the isogenic candidalysin mutant ece1Δ/Δ (MOI 3). Macrophage plasma membrane permeabilization was quantified by DRAQ7 in live-cell imaging. Shown are means and SEM from three independent replicates. At least 3500 macrophages were quantified per experiment, for each experimental group. B LDH release from hMDMs infected with C. albicans wild type (WT) or ece1Δ/Δ at 24 h. NINJ1 was inhibited with 50 mM glycine. Shown are means and SEM from four independent donors (two-tailed t-test with Welch’s correction * p ≤ 0.05) C Crosslinking-Western blot experiments showing oligomerised NINJ1 in BMDMs following infection with wild type (WT) or ece1Δ/Δ C. albicans. Another independent repeat of this experiment using BN-PAGE is shown in Fig S7B. Unprocessed blots for actin are shown in Fig. S4D. D Control Ninj1+/+and Ninj1–/– iBMDMs challenged with the indicated C. albicans isolates and imaged to quantify DRAQ7-positive macrophages (MOI 3). The hyphal index (h.i., calculated from hyphal length divided by width) within macrophages is indicated on each graph28. Shown are means and SEM for three independent experiments. At least 3000 macrophages were quantified per experiment, for each experimental group. E Time-lapse images of C. albicans strain P78042 escaping from control Ninj1+/+ or Ninj1–/– iBMDMs. The white dashed line demarcates intact macrophages containing C. albicans. Yellow arrows indicate escaped hyphae and their extracellular growth over time. The DRAQ7 signal (indicating permeabilized macrophages) is overlayed in red. Scale bar=100 µm. Shown are representative images from three independent replicates. See also Movie S2. F Confocal imaging of escaped C. albicans (strain P78042), stained with the fungal cell wall dye calcofluor white (blue). Calcofluor white differentially labels escaped fungi42. Control Ninj1+/+ or Ninj1–/– iBMDMs were stained with phalloidin (red). Images were taken at 8 h post-infection. Scale bar=100 µm. G Quantification of escaped C. albicans based on fluorescence (see Materials and Methods). An example of full field images used for the quantification are shown in Fig S9A. Shown are means and SEM from three independent experiments (two tailed t-test * p ≤ 0.05). To further test the contributions of NINJ1 and candidalysin in Candida infections, we used C. albicans clinical isolates that display substantial diversity in candidalysin expression levels. The reference strain SC5314 (used in most of our experiments) readily forms hyphae under in vitro conditions and secretes high levels of candidalysin49. We selected four additional bloodstream infection isolates with reduced candidalysin expression52–54. These isolates also display lower hyphal growth within macrophages28. Deletion of Ninj1 strongly rescued macrophages in infections with all low-candidalysin isolates, and the rescue was stronger than with the candidalysin-high strain SC5314 (Fig. 5D). Ninj1–/– macrophages were protected from plasma membrane permeabilization for over 20 h upon infection with strain P78042, whereas for P57055, P57072 and P76067 plasma membrane permeabilization started late in Ninj1–/– macrophages and progressed more slowly than with SC5314 (Fig. 5D). For instance, at 20 h post-infection, plasma membrane permeabilization was seen for 30% of Ninj1–/– macrophages for SC5314, 15% for P57055, 17% for P57072, 8% for P76067 and 6% for P78042. Collectively, these results show that NINJ1 has a conserved role in macrophage plasma membrane damage across diverse C. albicans strains and an increasingly important role with strains that express lower candidalysin levels. Invasive hyphal growth and secreted candidalysin together damage macrophage membranes to promote immune escape of C. albicans42,51,55. Based on data in Fig. 5D we predicted that C. albicans strains with reduced hyphal growth and candidalysin expression might use NINJ1-dependent plasma membrane damage as their major mechanism for egress. Indeed, this was the case. Strain P78042 showed reduced egress from Ninj1–/– macrophages, with few externalized hyphae observable (Figs. 5E–G, and S9A; Movie S2). In contrast, extensive escape of this strain was seen from wildtype macrophages, followed by proliferation of the externalized hyphae (Fig. 5E–G; Movie S2). Strains P57055, P57072 and P76067 were likewise delayed in their egress from Ninj1–/– macrophages (Fig. S9B, Movie S2). These findings determine that NINJ1-dependent macrophage rupture is a major fungal egress mechanism. Discussion In this study, we establish the mechanism by which glucose-starved macrophages lyse in response to fungal pathogens. We show that the mechanism is mediated by NINJ1, which causes macrophage plasma membrane permeabilization and rupture. This mechanism is conserved in both mouse and human macrophages, and establishes glucose starvation as a trigger for NINJ1 activation in infected macrophages. Our findings further show that supplementation of alanine, an important mammalian metabolite, inhibits NINJ1-dependent damage without providing a growth advantage to C. albicans. Moreover, NINJ1 is the dominant host effector of macrophage damage in response to C. albicans, since inactivation of NINJ1 has the biggest effect in reducing macrophage damage compared to other cell death programs studied to date. For C. auris, NINJ1 is the only host factor discovered so far driving macrophage damage. We also demonstrate that C. albicans uses NINJ1-dependent plasma membrane damage to egress from macrophages. This shows that, in addition to the reported role of NINJ1-dependent egress of norovirus particles from immune phagocytes56, much larger fungal hyphae (measuring tens of μm in length) escape from immune containment due to NINJ1-dependent membrane damage. This suggests substantial rupture and disintegration of the membrane structure by NINJ1 to allow for the release of a very large pathogen. This may contribute to the dissemination of infection, and it may also orchestrate inflammatory responses that control pathogens or even drive pathological inflammation during infection. Current infection studies in Ninj1 mutant mice support several of these possibilities. For example, Ninj1 mutant mice showed increased mortality upon bacterial infection with Citrobacter rodentium or Yersinia pseudotuberculosis33,57, and we show higher fungal burden in the spleen relative to kidneys in Ninj1 mutant mice (but not in wild type controls) following intraperitoneal infection with C. albicans (Fig. S6). However, Ninj1 mutant mice show reduced mortality in sepsis caused by bacterial flagellin, lipopolysaccharide (LPS) plus heat shock, and influenza A virus lung infection58–60. Collectively, these studies suggest that the outcome of NINJ1-inhibition in infected hosts may depend on the pathogen and stage of disease, and may be useful when uncontrolled inflammation becomes a driver of poor outcomes. As we show here and previously, glucose starvation causes changes in mitochondrial membrane polarization, whereby hyperpolarization is followed by depolarization coinciding with plasma membrane permeabilization and damage (Fig. 3) and1. Like our results with C. albicans, the ATP synthase inhibitor oligomycin causes mitochondrial hyperpolarization and triggers NINJ1-dependent macrophage membrane damage33. Therefore, changes to mitochondrial function are a possible trigger for NINJ1 activation in response to glucose starvation and metabolic dysfunction caused by C. albicans. Furthermore, we show that the fungal pore-forming toxin candidalysin plays a role in activating NINJ1. Our results are supported by data showing that bacterial pore-forming toxins streptolysin and listeriolysin activate NINJ133. The precise activating mechanisms for NINJ1 oligomerization and membrane rupture are still to be resolved and may differ depending on the stimulus. However, the current consensus is that changes to membrane structure, such as movement of phospholipids (scrambling), swelling or mechanical stress, are involved47,61–63. Candidalysin damages mitochondrial membranes and the plasma membrane of host cells49,50,64, providing the likely mechanism by which it activates NINJ1. Interestingly, a recent study showed that, in addition to membrane damage caused by pore-forming toxins, mechanical damage is needed for full rupture mediated by NINJ163. In line with our results with C. albicans, NINJ1-dependent membrane rupture triggered by mechanical challenge does not require the characterised cell death programs63. In the case of C. albicans, the mechanical damage may be provided by the growing fungal hyphae exerting force on the membrane55. Based on these considerations, we propose that during infection, a combination of metabolic dysfunction, membrane-damaging toxins secreted by pathogens and mechanical stress on immune cell membranes from microbial growth are key stimuli for triggering NINJ1-mediated damage and PMR. Our findings further show that supplementation of alanine rescues glucose-starved macrophages from C. albicans-induced membrane damage in a NINJ1-dependent manner. Alanine is an important metabolite under metabolic stress38, and our data in infected mice is consistent with disruption of amino acid homeostasis in C. albicans-infected animals. Although host amino acid homeostasis was broadly perturbed by C. albicans, of all of the amino acids that we tested in this study and previously1 only alanine and glycine rescue the integrity of glucose-starved macrophages, and we show that alanine metabolism is not required. This indicates that amino acid metabolism cannot compensate for disrupted glucose metabolism in Candida-infected macrophages. Consistent with this, we show that alanine rescues macrophages without correcting their metabolic dysfunction or inhibiting cell death, in line with studies showing that NINJ1-induced membrane damage occurs independently of metabolic dysfunction during cell death33,47,65. Alanine has been found to inhibit macrophage lysis and NINJ1 oligomerisation downstream of pyroptosis48,66. However, we show here that supplementation of alanine causes a reduction in both membrane permeabilization and PMR in C. albicans-infected macrophages in a manner that is independent of pyroptosis, apoptosis or necroptosis. Accordingly, the proteolytic processing of caspase-1, GSDMD and IL-1ß in response to C. albicans is not prevented by alanine, although the amount of IL-1ß released by infected macrophages is reduced. In addition to alanine, glycine, and the GABA receptor agonist muscimol also display NINJ1-inhibitory activity48,65. The biochemical mechanism by which these metabolites inhibit NINJ1 oligomer formation remains to be understood48,65. Alanine and glycine are structurally similar, and muscimol also shares features of its chemical structure with glycine65. Therefore, the mechanism of NINJ1 inhibition by these molecules may be conserved. The requirement for NINJ1 for both membrane permeabilization and PMR of C. albicans-infected macrophages is similar to ferroptosis, infection with Yersinia or Salmonella, treatment with the lipopolysaccharide (LPS) in the presence of heat shock and mechanical membrane challenge as a trigger for NINJ157,59,63,67. Downstream of pyroptosis, NINJ1 is required for terminal PMR but has no role in the earlier GSDMD-mediated membrane permeabilization event or secretion of IL-1ß33. The explanation is that, during pyroptosis, membrane permeabilization and IL-1ß secretion depend on GSDMD pores, which form independently of NINJ133. Given that, as we and others have shown, C. albicans triggers NLRP3-dependent pyroptosis40,41, the question is why NINJ1 mediates membrane permeabilization in our experiments. The answer is that C. albicans triggers pyroptosis early after macrophage infection40,41, while glucose starvation occurs later and triggers NINJ1-dependent damage independently of GSDMD or pyroptosis, as we show here. Consistently, we show that alanine only needs NINJ1 but not any of the pyroptotic factors to rescue macrophages, and the same is true for glycine. Therefore, downstream of glucose starvation, GSDMD has no role in macrophage membrane damage, explaining why NINJ1 is involved in both membrane permeabilization and PMR under these conditions. Inactivation of NINJ1 does not impair the release of IL-1ß in response to the mentioned bacterial pathogens and LPS plus heat shock57,59, although Ninj1 mutant mice had lower levels of plasma IL-1ß in response to infection with Escherichia coli58. We show that, in response to C. albicans, inhibition of NINJ1 by alanine resulted in reduced macrophage IL-1ß secretion, and genetic inactivation of Ninj1 reduced IL-1ß secretion from immortalised mouse macrophages (iBMDMs) but not by primary mouse macrophages (BMDMs). In all cases, however, the release of large pro-inflammatory danger-associated molecular patterns (DAMPs) by C. albicans-infected macrophages, specifically LDH, was reduced by both genetic and alanine-based inhibition of NINJ1. This is consistent with NINJ1-dependent PMR releasing large pro-inflammatory DAMPs in response to many upstream signals33. Using diverse clinical isolates of C. albicans, we further show that NINJ1-dependent PMR also promotes the release of the ultimate large DAMP, the large hyphal cells of the fungal pathogen itself, thereby driving immune escape. Previous work by us and others has shown that C. albicans uses several mechanisms to egress from macrophages and disseminate. These include early escape via GSDMD-driven pyroptosis, as well as hyphae- and candidalysin-induced macrophage membrane damage40–42,51,55. However, these established mechanisms do not account for several findings. Firstly, C. albicans clinical strains are diverse, with several unable to form robust hyphae in vitro, activate pyroptosis or express high levels of candidalysin28,52–54. Secondly, only a proportion of macrophages in the population trigger pyroptosis upon C. albicans challenge28,40. We now show that NINJ1 plays an increasingly important role in macrophage membrane damage and egress for C. albicans isolates with reduced hyphal formation and candidalysin expression. These findings identify NINJ1 as a central host effector of fungal escape from macrophages. Our data with high – and low-candidalysin isolates and candidalysin mutant strains show that NINJ1 works together with candidalysin to damage macrophage membranes and promote C. albicans escape. In conclusion, our study identifies NINJ1 as the host effector of membrane damage following glucose starvation of Candida-infected macrophages. We propose that NINJ1 might be a general effector of PMR upon glycolytic dysfunction caused by a broad range of pathogens, such as Salmonella23,65. Moreover, given the central role of NINJ1 in performing PMR downstream of cell death pathways used by diverse pathogens to egress from macrophages68, we posit that NINJ1 may be commonly hijacked as a pathogen egress factor. As such, a broad understanding of NINJ1 functions in responding to host metabolic stress caused by infection could shed light on the mechanisms that balance pathogen containment within immune phagocytes with orchestrating pro-inflammatory immune responses that control infections. Methods Ethics statement All procedures involving mice for the isolation of BMDMs were conducted in compliance with protocols approved by the Monash University Animal Ethics Committee (approval ID ERM37724). Experiments involving the collection of human blood samples received ethical clearance from the Monash University Human Research Ethics Committee (ERM 44451). All donors signed consent forms. Experiments involving C. albicans infection of mice and blood collection (Figs. 1 and S1) were approved by the Monash University Animal Ethics Committee (approval ID ERM36304). Experiments involving in vivo mouse infections in Ninj1–/– and wild type control mice (Fig S6) were approved by the University of Queensland (UQ) Animal Ethics Committee and conducted following federal legislation on animal welfare (2024/AE000019, 2025/AE000348). Isolation of hMDMs in Fig. S5 was conducted according to the principles of the Declaration of Helsinki. The blood donation protocol and use of blood for isolation of human monocyte-derived macrophages were approved by the institutional ethics committee of the University Hospital Jena (permission number 2207–01/08). Candida strains and media The strains used in this study are listed in Table S1. Unless stated otherwise, the clinical isolate SC5314 was the main strain used in this study. The tye7Δ/Δ gal4Δ/Δ strains are described in ref. 69. All clinical strains of C. albicans were obtained from BEI Resources, NAID, NIH. Candida strains were routinely cultured on YPD medium composed of 1% yeast extract, 2% peptone, 2% glucose, and solidified with 2% agar for 2 days. For experiments requiring overnight liquid cultures, such as growth curve kinetics, a single colony was picked from a freshly streaked YPD agar plate and incubated in liquid YPD at 30 °C for 18 h. Cultures were then diluted to an initial OD600 of 0.1 using prewarmed bone marrow-derived macrophage (BMDM) medium before use in assays. BMDM medium consisted of RPMI 1640 supplemented with 12.5 mM HEPES, 10% fetal bovine serum (FBS), 20% L-cell conditioned medium providing macrophage colony-stimulating factor, and 100 U/ml penicillin-streptomycin. RPMI 1640 (Thermo Fisher, catalog no. 11875093) was used as a base and supplemented with either glucose, alanine or glycine at 10 or 40 mM. For filamentation assays, macrophage infection studies and phagocytosis assays, a single colony was selected from fresh YPD solid medium and patched onto new plates and incubated at 30 °C overnight. The patches were suspended in PBS the following day and diluted to the desired concentration for the experiments, as determined by counting using a hemocytometer. Strain construction Primers used to construct the mutant strains in this study are listed in Table S2. The ECE1 open reading frame (ORF) in C. albicans SC5314 was deleted using a CRISPR-Cas9 protocol70. The deletion of the ECE1-ORF was confirmed via colony PCR, and the Cas9-expression vector was excised by Flp-recombination. The ECE1-complemented strain was generated using the SAT1-Flipper method71. The cloned sequences were verified by Sanger sequencing. The ECE1 complementation cassette was excised using SacI/ApaI and introduced into the C. albicans ece1∆/∆ strain (M2974). Correct integration was confirmed by colony PCR at the cassette junctions, and the SAT1-marker was excised by Flp-recombination. The homozygous deletion of ALT1 and the complemented strain were constructed in the SN152 strain (his1− leu2− arg4 − )72, using the HIS1 and LEU2 markers for deletion and the ARG4 marker for complementation. The complemented strain has one copy of ALT1 reintroduced at the LEU2 locus. Transformants were confirmed by PCR. The reference strain SN425 (HIS1+ LEU2+ ARG4+) was used as the control. Cell culture experiments Isolation of murine bone marrow-derived macrophages (BMDMs) and human monocyte-derived macrophages (hMDMs) To isolate murine BMDMs, bone marrow cells were extracted from 6-8-week-old mouse femurs and tibias of either C57BL/6 mice obtained from the Monash Animal Research Platform or Nlrp3 –/–, Gsdmd –/– and Ninj1 –/– mice obtained from the Walter and Elisa Hall Institute and the Hudson Institute, respectively. Bone marrow containing monocytes was flushed out using 10 ml of BMDM medium1. The cells were then incubated for 18–24 h at 37 °C with 5% CO2. Following incubation, non-adherent cells were transferred to fresh BMDM medium and allowed to differentiate into BMDMs for 5–7 days. To isolate hMDMs (Fig. 1), whole blood was obtained from healthy donors using Histopaque-1077 (Sigma-Aldrich) via density gradient centrifugation. Monocytes expressing CD14 and CD16 were subsequently enriched from peripheral blood mononuclear cells (PBMC) fraction using the Pan Monocyte Isolation Kit and magnetic labeling system (Miltenyi Biotec). The isolated monocytes were then seeded in 25 cm² tissue culture flasks and differentiated into human monocyte-derived macrophages (hMDMs) by culturing for 7 days at 37 °C with 5% CO₂ in RPMI 1640 medium supplemented with 15 mM HEPES, 10% fetal bovine serum (Serana, Fisher Biotech), 100 U/ml penicillin-streptomycin (Sigma-Aldrich), and 50 ng/ml macrophage colony-stimulating factor (M-CSF, R&D Systems). For hMDM isolation in Fig. S5A, PBMCs were isolated from buffy coats obtained from healthy donors using Histopaque-1077 (Sigma-Aldrich) density gradient centrifugation. CD14-positive monocytes were subsequently purified by magnetic-activated cell sorting (MACS) using the autoMACS® system (Miltenyi Biotec), according to the manufacturer’s instructions. A total of 1 × 10⁷ CD14⁺ monocytes were seeded into 175 cm2 flasks and cultured in RPMI 1640 (Thermo Fisher Scientific) and 10% FBS. Differentiation into macrophages was induced by adding 50 ng/mL rhM-CSF (ImmunoTools), and cells were incubated for seven days at 37 °C, 5% CO₂. After differentiation, macrophages were detached using 50 mM EDTA in phosphate-buffered saline (PBS), and reseeded at a density of 2 × 105 cells/ml. Then 200 µl per well of a 96-well plate (TPP, 4 × 104 cells/well) were added for subsequent experiments. Live-cell imaging Macrophages were harvested, seeded and stained following protocols detailed in our previous studies1,24. Following staining, macrophages were infected with Candida at a yeast-to-macrophage ratio of either 1:1, 3:1 or 6:1. After the phagocytosis step (1 h), extracellular yeast cells were removed by gentle washing with phosphate-buffered saline (PBS). Where specified, BMDM culture medium was supplemented with metabolites including glucose, alanine and glycine at concentrations detailed in the figure legends. These metabolites were added after the 1 h phagocytosis and wash steps. For experiments assessing the role of caspase inhibition, macrophages were pre-incubated with 10 µM Quinoline-Val-Asp-Difluorophenoxymethylketone (QVD) for 1 h. Following this, cells were washed and maintained in fresh BMDM medium prior to infection with C. albicans. Control (uninfected) macrophages were subjected to the same treatment conditions. After infection, culture media in both experimental and control wells were replaced with fresh medium either with or without 10 µM QVD, which was maintained for the duration of the assay. All conditions included 0.6 mM DRAQ7 (Abcam) to monitor plasma membrane permeabilization in macrophages. Live-cell imaging was carried out using a Leica AF6000 LX epifluorescence microscope equipped with a 20× objective lens. Image analysis and quantification were performed using CellProfiler v2.1.1, following protocols established in our laboratory42,73. Time-lapse image sequences were compiled into movies using ImageJ software, and all quantitative data were visualized using Prism 10 (GraphPad Software, San Diego, CA). For human macrophage experiments, cells were removed from PBS containing 2 mM EDTA and 2% FBS following a 10-minute incubation at 37 °C in 5% CO2. The cells were subsequently washed multiple times using an 18 G needle attached to a 10 ml syringe. The separated hMDMs were plated at 5 ×10⁴ cells/well in a 96-well plate containing RPMI 1640 media supplemented with 15 mM HEPES, 10% fetal bovine serum (Serana, Fisher Biotech), and 100 U/ml penicillin-streptomycin, then left to incubate at 37 °C and 5% CO2 overnight prior to infection24. For visualization in live-cell assays, hMDMs were labeled with 1 µM CellTracker Green CMFDA (Thermo Fisher, C7025) for 25 min, following the same staining protocol used for BMDMs. Subsequently, cells were primed by incubation in RPMI 1640 supplemented with 15 mM HEPES, 10% FBS, and 50 ng/ml lipopolysaccharide (LPS, Sigma-Aldrich) for 2 h at 37 °C and 5% CO₂. Post-priming, hMDMs were infected with Candida at a multiplicity of infection (MOI) of 3. After a 1 h infection period, the subsequent steps for live-cell imaging, including washing and analysis, were performed identically to the BMDM protocol described above. For experiments with immortalized bone marrow-derived macrophage (iBMDMs) derived from C57BL/6 Cre-J2 mice43, including wild-type and genetically modified lines lacking caspase-1, caspase-11, caspase-12, caspase-8, or Receptor-Interacting Protein Kinase 3 (RIPK3) deficient in pyroptotic, necroptotic, and extrinsic apoptotic pathways or control and Ninj1 –/– macrophages described in ref. 74 and Table S1, cellswere cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin-streptomycin. Cells were maintained at 37 °C in a humidified incubator with 5% CO₂. For live-cell imaging assays, iBMDMs were harvested by gentle scraping (BD Falcon cell scraper) and seeded into tissue culture-treated 96-well plates at a density of 8 × 104 cells per well. After overnight incubation to allow cell attachment recovery and multiplication (to 1 × 105), macrophages were infected with C. albicans at an MOI of 3. Imaging and subsequent data acquisition and analysis were performed following the same protocol established for primary BMDM experiments. BlaER1 cell culture and transdifferentiation The B-cell leukemia cell line C/EBPαER clone 1 (BLaER1) was previously generated75 and cultured and transdifferentiated as described in their work with minor adjustments regarding cell numbers. In short, BLaER1 cells were cultured in RPMI 1640 medium supplemented with 10 mM HEPES, 100 U/ml penicillin, and 100 µg/ml streptomycin (all Thermo Fisher Scientific) and 10% fetal bovine serum (FBS) (BLaER1 medium) at 37 °C, 5% CO2. Cells were passaged at a sub-cultivation ratio of 1:3–1:5 every 2 to 3 days to a maximum of 30 passages. For transdifferentiation, BLaER1 cells were adjusted to 3.3 × 105 cells/ml in BLaER1 medium supplemented additionally with 10 ng/ml recombinant human macrophage colony-stimulating factor (rhM-CSF, ImmunoTools), 10 ng/ml recombinant human interleukin 3 (rhIL-3, ImmunoTools) and 200 nM β-estradiol (Sigma-Aldrich) (Transdifferentiation medium). Three mL per well of this suspension were seeded in 6-well plates (TPP) and incubated at 37 °C, 5% CO2 for seven days. Every two to three days, 1.5 ml of the medium was replaced with fresh, transdifferentiation medium. At day seven, the undifferentiated suspension cells were removed by aspirating the supernatant, while the transdifferentiated, adherent cells (tdBLaER1) were carefully harvested by thorough washing of the wells with medium. The concentration of the tdBLaER1 was adjusted to 4 ×105 cells/ml in transdifferentiation medium. Of this suspension, 200 µl/well were seeded into 96-well plates (TPP). The cells were left at room temperature for 20 – 30 min to allow attachment and incubated at 37 °C, 5% CO2 overnight for experiments on the following day. The cells were checked microscopically on the days of the medium exchange. Transdifferentiated cells appeared as GFP-positive, attached, and elongated with a spindle-shaped, macrophage-like morphology. Preparation of supernatants and cell lysates for IL-1β ELISA, LDH release, and immunoblotting The procedure for supernatant and cell lysate collection was performed in BMDM or iBMDM (control and Ninj1–/–) cells. Macrophages were seeded at a density of 5 × 10⁵ cells per well in 24-well plates using BMDM medium, following the protocol described under “Live-cell imaging”. Cells were primed with 50 ng/ml lipopolysaccharide (LPS) for 3 h at 37 °C in 5% CO₂, after which they were either left uninfected or challenged with C. albicans (strain SC5314, MOI 3) for 1 h. Following infection, wells were washed three times with PBS to remove non-phagocytosed fungal cells and replaced with 250 µl of fresh BMDM medium. Where relevant, media was supplemented with 10 mM alanine or glycine at this point. Infected and control cells were then incubated for an additional 3, 14 and 16 h. As a positive control for inflammasome activation, macrophages were treated with 10 µM nigericin or 0.01% Triton-X for 3 h. At each time point, supernatants were removed and aliquoted for ELISA (100 µl), Western blot (75 µl), and LDH assay (75 µl). Aliquots designated for ELISA and LDH assays were subsequently stored at −80 °C. Those reserved for Western blot analysis were combined with 25 µl of 4x sample buffer (RSB; ThermoFisher) containing 5% β-mercaptoethanol in microfuge tubes, heated to 95 °C for 10 min, and then stored at −20 °C. Following supernatant removal, 150 µl of 1x RSB buffer supplemented with 2.5% β-mercaptoethanol was dispensed into each well, and a 1 ml pipette tip was used to dislodge the cells to obtain the lysate fraction. The resulting lysate was transferred into 1.5 ml microfuge tubes, heated to 95 °C for 10 min, and stored at −20 °C24. For tdBLaER1 cells and hMDMs LDH release assays, cells were primed with 50 ng/ml LPS from Escherichia coli O55:B5 (Sigma Aldrich) for 2 h at 37 °C, 5% CO2. During priming, glycine from a sterile-filtered 1 M stock solution in double-distilled water was added to RPMI 1640 to a final concentration of 50 mM. After priming, the LPS-containing medium was aspirated, and 100 µl fresh RPMI 1640 containing either 50 mM L-glycine or no additional supplement was added and incubated for 10 min prior to infection to block NINJ1 oligomerization, according to the procedure described for human primary macrophages by ref. 48. C. albicans strains were adjusted to MOI 1 for tdBLaER1 and MOI 3 for hMDMs as described above, either in 100 µl RPMI 1640 or 100 µl RPMI 1640 + 50 mM L-glycine, depending on the condition. For infection, 100 µl of the adjusted strains were added to the cells and incubated for 24 h at 37 °C, 5% CO2. IL-1β quantification ELISA Levels of IL-1β in culture supernatants were quantified using the Mouse IL-1β/IL-1F2 DuoSet ELISA kit (R&D Systems, DY401), following the manufacturer’s protocol. Absorbance was read at 450 nm with a correction wavelength of 540 nm using a Tecan Spark 10 M microplate reader. A standard curve was generated using the recombinant IL-1β standards supplied in the kit, and cytokine concentrations in experimental samples were calculated by interpolation from this curve using GraphPad Prism 10.0 (GraphPad Software, San Diego, CA). Lactate dehydrogenase (LDH) and ATP assays Cell rupture was assessed by measuring lactate dehydrogenase (LDH) release into cell culture supernatants using the CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega, G1780), following the protocol provided by the manufacturer. Absorbance was recorded at 492 nm using a Tecan Spark 10 M microplate reader. Where indictaed, LDH activity in each sample was expressed as fold change relative to the positive control treated with detergent (Triton-X). For tdBLaER1 cells and hMDMs LDH release assays, infection plates were centrifuged at 250 × g for 10 min, the supernatants were collected and diluted 1:5 in PBS. LDH concentrations were measured using the Cytotoxicity detection kit (Roche) according to the manufacturer’s instructions. Cellular ATP levels were quantified using the CellTiter-Glo Luminescent Cell Viability Assay (Promega) according to the manufacturer’s instructions. Briefly, cells were seeded, infected and treated as described in the live cell imaging protocol. Following treatment, supernatants were removed and retained, and macrophages were lysed using 0.25% of Triton-X, lysates spun to remove C. albicans. A volume of 150 ul of both supernatants and lysates was aliquoted to a 96 well tray, and an equal volume of CellTiter-Glo reagent was added to each well, plates were incubated at room temperature for 10 min for luminescent signal stabilization and measured using a plate reader. Total luminescence was determined by the addition of outputs for supernatants and lysates for each condition. Western blot analysis For detection of IL-1β, caspase-1, and Gasdermin D (GSDMD), cell lysates and/or supernatants were denatured by boiling at 95 °C for 10 min prior to electrophoresis. Samples were then separated on 4–12% Criterion™ XT Bis-Tris Protein Gel (Biorad) and transferred overnight onto Immobilon-P Membrane, PVDF, 0.45 uM (Millipore). Membranes were briefly stained with Ponceau S to confirm equal loading and transfer. Following blocking with 5% (v/v) skim milk in TBS containing 0.1% (v/v) Tween-20 (TBS-T) for 1 h at room temperature, membranes were incubated overnight at 4 °C on a rotating platform with the following primary antibodies (1:1000 dilution): anti-IL-1β (R&D Systems, #AF-401-NA), anti-caspase-1 (Adipogen, AG-20B-0042-C100), and anti-GSDMD (Abcam, ab209845). The next day, membranes were washed and probed with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:10,000 dilution) for 1 h at room temperature. Signal was developed using SuperSignal™ West Femto Maximum Sensitivity Substrate (Thermo Fisher 34094) and imaged using FUJI medical X-ray films. Figures were prepared using Adobe Illustrator. For detection of NINJ1 in cell lysates, cells were seeded, infected and treated as detailed in preparation of samples for immunoblotting, with the exception of using 150 ul of RIPA buffer per well for harvesting lysates (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton-X, 0.5% sodium deoxycholate, 0.1% SDS and 5 mM EDTA). Samples were denatured at 100 °C for 5 min, resolved on 12% SDS–PAGE gels, and transferred to PVDF membranes. Membranes were blocked in 5% milk in TBS-T for 1 h (room temperature) and then incubated for 1 h with primary antibodies diluted in blocking buffer: anti-actin (Sigma MAB1501; 1:5000) or anti-NINJ1 Invitrogen (Cat#: BS-11105R). Following three 10-min washes in TBS-T, membranes were incubated for 1 h with either HRP-conjugated Goat anti-Rabbit IgG (H + L) (Cat#: 31460; RRID: AB_228341) or anti-mouse IgG (Sigma A4416; 1:10,000) in 5% milk/TBS-T. Proteins were detected using enhanced chemiluminescence (SuperSignal West Dura; Thermo Fisher 34075) and visualized on FUJI X-ray film. Actin served as a loading control. For reprobing, membranes were stripped in 0.5 M NaOH for 10 min, washed sequentially with water, TBS-T, and water (5 min each) and dried. Quantification of NINJ1and actin protein levels was performed using densitometric quantification on FIJI software (NIH). For detection, cross-linked NINJ1 cells were seeded, infected and treated as detailed in preparation of samples for immunoblotting. Crosslinking was performed as described in ref. 76. Cells were solubilized in lysis buffer containing 66 mM Tris–HCl (pH 7.4), 2% SDS, 10 mM DTT and NuPAGE LDS sample buffer (Thermo Fisher). Prior to running the gel, the samples were denatured at 97 °C for 10 min. Protein samples were resolved on 4–15% gradient polyacrylamide gels (Bio-Rad) and transferred to PVDF membranes. Primary antibodies used for detection included anti-mouse NINJ1 PA5-95755 (RRID: AB_2807557 1:1000), and anti-actin (Sigma MAB1501; 1:5000). Secondary antibodies and visualisation are as detailed above for NINJ1 detection in cell lysates. Infection and RNA isolation of tdBLaER1 cells and hMDMs for analysis of Ninj1 expression For host RNA extraction upon C. albicans infection, 1 × 106 and 2 × 106 of hMDMs and tdBlaER1 cells, respectively, were seeded in 6-wells at the concentrations described above. On the day of infection, the medium in each well was replaced with 2 ml RPMI without FBS, infected with C. albicans at an MOI of 2, and incubated at 37 °C, 5% CO2. Samples for RNA isolation were collected at 1 h, 3 h, and 6 h post-infection. The well content was removed and replaced with 1 ml of RNeasy Lysis (RLT) buffer (Qiagen) supplemented with 1% β-mercaptoethanol (Roth). Cells were detached using a cell scraper ( < 3 min) and centrifuged for 10 min (20,000 × g, 4 °C). The host RNA-containing supernatant was transferred to a new tube, immediately shock-frozen in liquid nitrogen, and stored at −80 °C until further processing. Once thawed, the supernatant was mixed with an equal volume of 70% ethanol (prepared in diethyl pyrocarbonate [DEPC]-treated water), and total RNA was isolated using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. Reverse transcription-quantitative PCR (RT-qPCR) The RNA (500 ng) was treated with Baseline-ZERO™ DNase (Biozym) according to the manufacturer’s guidelines and subsequently transcribed into cDNA using 0.5 µg Oligo(dT)12-18 Primer, 200 U Superscript™ III Reverse Transcriptase, and 40 U RNaseOUT™ Recombinant RNase Inhibitor (Thermo Fischer Scientific). The obtained cDNA was diluted 1:5 and used for RT-qPCR with GoTaq® qPCR Master Mix (Promega) in a CFX96 thermocycler (Bio-Rad). Expression levels were normalized to beta-actin. All primer sequences are listed in Table S2. Blue Native PAGE For native gel analysis, samples were prepared following the protocol provided by the manufacturer (Thermo Fisher Scientific). In short, cells were lysed and then subjected to centrifugation at 100 × g for 2 min. The resulting pellet was resuspended in 1× Sample Buffer supplemented with 1% digitonin. After mixing the suspension gently by pipetting five times, it was spun down at 20,000 × g for 30 min at 4 °C. The supernatant was carefully collected for analysis. Proteins were separated using 3–12% NativePAGE™ Bis-Tris Mini Protein Gels (Thermo Fisher Scientific, BN1002BOX Gels were then transferred onto PVDF membranes and subjected to immunoblotting. Detection of NINJ1 was performed using a primary Rabbit anti-NINJ1 Invitrogen Cat#: BS-11105R and PA5-95755; RRID: AB_2807557 antibody at 1:1000, while secondary Donkey anti-Rabbit IgG (H + L) (Cat#: A-31573; RRID: AB_2536183) and Goat anti-Rabbit IgG (H + L) (Cat#: 31460; RRID: AB_228341) antibodies was used at a 1:5000 dilution. Phagocytosis assay BMDMs were seeded at a density of 5 × 10⁵ cells in 500 µl of a 24-well plate and incubated overnight at 37 °C with 5% CO₂. The following day, macrophages were infected with C. albicans strains at an MOI of 2, and co-incubated for 1 h in BMDM medium. Non-phagocytosed C. albicans cells were removed by washing the wells three times with PBS. Five images per well were captured using the EVOS FL AUTO imaging system at 40x magnification. The number of internalized C. albicans cells and macrophages was manually counted (at least 100 macrophages for the alt1Δ/Δ mutant experiments and all the macrophages in a field of view for the alanine supplementation experiments) using the Cell Counter plugin in ImageJ. The phagocytosis index was calculated as the ratio of engulfed C. albicans cells to the total number of macrophages per field. Candida survival assay BMDMs were seeded at a density of 1 × 10⁵ cells per well in 150 µL of BMDM medium in 96-well tissue culture plates. Cells were incubated overnight at 37 ºC with 5% CO₂ to allow for adherence. The following day, BMDMs were infected with C. albicans SC5314 at a multiplicity of infection (MOI) of 2. Candida cells were counted using a hemocytometer, and 2 × 10⁵ yeast cells were added per well. Plates were incubated at 37 °C for 1 h to allow phagocytosis. After incubation, non-phagocytosed Candida was removed by washing the wells three times with sterile PBS. Infected macrophages were then treated either with no supplementation (control) or with 10 mM L-alanine, by addition to the medium. To assess Candida survival at selected time points, the medium was removed, and macrophages were lysed by adding 150 µL of ice-cold distilled water per well. Lysates were collected, diluted in 1× PBS, and 100 µL of each sample was plated on YPD+Uri agar plates. Plates were incubated at 30 °C for 48 h, after which colony-forming units (CFUs) were counted to quantify Candida survival. Growth curves analysis C. albicans strains were adjusted to an optical density (OD₆₀₀) of 0.1 and suspended in BMDM medium, either without supplementation or supplemented with 10 mM L-alanine or D-alanine (BMDM medium: RPMI 1640 with 12.5 mM HEPES, 20% L-cell conditioned medium, 15% heat-inactivated and filtered fetal bovine serum, and 100 U/ml of penicillin-streptomycin). The growth of the strains was monitored at 37 °C using a Tecan Spark 10 M microplate reader, with OD₆₀₀ measurements taken every 30 min for 24 h. Three biological replicates, each with three technical replicates, were performed for the experiment. Filamentation assay Candida strain suspensions were prepared at a concentration of 1 × 10⁷ cells/ml, as determined by hemocytometer. A volume of 10 µl of this suspension was added to 140 µl of BMDM medium, supplemented with either 10 mM L-alanine or D-alanine, in a 96-well plate. The plate was placed under live-cell imaging conditions at 37 °C with 5% CO₂. Images were captured every 15 min for a total duration of 24 h. Confocal microscopy Immortalized bone marrow-derived macrophage (iBMDMs) derived from control and Ninj1+/+ macrophages in the C57BL/6 J Cas9+ background, described in ref. 74 were used. Cells were seeded at 1 × 10⁵ cells per well in a cell culture chamber slide (8-well, catalogue no. 94.6170.802) in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin-streptomycin. Cells were maintained at 37 °C in a humidified incubator with 5% CO₂. Cells were allowed to adhere and recover overnight at 37 °C in a humidified incubator with 5% CO₂. Macrophages were infected with C. albicans at a yeast-to-macrophage ratio of 3:1, and phagocytosis (1 h), extracellular yeast cells were removed by gentle washing with PBS. At the 7 h post-infection, media was spiked with 10 μg/ml of calcofluor white (CFW) and allowed to proceed for (8 h total) before fixation with 2% paraformaldehyde for 20 min protected from light. Samples were covered in foil and stored overnight in PBS. The following day, fixed cells were stained with Phalloidin-iFluor 555 (1:1000 dilution, Abcam, ab176756) in PBS with 0.1% Triton X-100 (Sigma, T9284) for 40 min at room temperature. The chambers were then rinsed with PBS three times before confocal imaging on the Zeiss 980 LSM microscope. 16-bit, 1024×1024 frame px frame size images were captured using a Plan-Apochromat 40x/1.3 NA objective lens. Tile scans of 1357.94 ×1357 µm area were captured for each well (two per biological repeat). Analysis (to add to the end of Image J info): Segmentation of CFW-positive C. albicans hyphae (escaped cells) was performed using the Labkit Image J plugin. An Image J macro that used a Labkit classifier file was used to generate total CFW area values for each biological repeat. Images were processed using ImageJ 1.54 f77. Transmission electron microscopy Wildtype and Ninj1+/+ iBMDM macrophages were seeded at a density of 5 × 10⁵ cells per well in 24-well plates using Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U/ml penicillin-streptomycin, following the protocol described under “Live-cell imaging” methods. Macrophages were infected with Candida clinical isolate P78042 at an MOI of 3 and were prepared for routine TEM using the PELCO BioWave (Ted Pella, Inc.). Samples were first fixed in Karnovsky’s buffer (2% paraformaldehyde, 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4), rinsed with 0.1 M sodium cacodylate buffer, and post-fixed in 2% OsO₄ with 1.5% potassium ferrocyanide. After a water wash, samples were stained with 1% thiocarbohydrazide at 50 °C, rinsed, and then exposed to 2% OsO₄ in cacodylate buffer, followed by another water wash. They were en bloc stained overnight at 4 °C in 2% aqueous uranyl acetate, then processed with a BioWave step at 50 °C. After washing, samples were dehydrated through an ethanol series (30%, 50%, 70%, 90%, and three changes of 100%). Finally, they were infiltrated with LX112 resin (33%, 66%, then three changes of 100%). Resin-filled Beem capsules were inverted over the wells and polymerized at 60 °C. Ultrathin sections (70 nm) were cut using a Leica UC7 ultramicrotome (Leica Microsystems) and imaged at 80 kV on a JEOL1400 Plus TEM equipped with a high sensitivity bottom mount CMOS ‘Flash’ camera. Infection of Ninj1–/– mice Mice were maintained in ventilated cages (4-5 mice per cage) with constant access to food and water on a 12-h light-dark cycle in a specific pathogen-free facility. The chow was Rat and Mouse cubes (SF00-100) from Specialty Feeds (Western Australia). C57BL/6 J mice were purchased from Ozgene (Pt Ltd, Perth, WA) or littermate controls and Ninj1–/– (C57BL/6N-Ninj1-ENU-KO)33 were housed in specific-pathogen-free conditions at the University of Queensland. C. albicans ATCC MYA-2876 (SC5314) was grown for 12 h on CHROMagar TM Candida plates at 37 °C. C. albicans cells were harvested by washing the CHROMagar TM plate with 5 ml of PBS. C. albicans cells were then centrifuged, washed twice, and resuspended in dPBS. The concentration of C. albicans cells was determined visually by Trypan Blue counting. The C. albicans stock was then diluted further in dPBS to achieve the desired concentration for in vivo infection (5 × 107 C. albicans cells/mL). C57BL/6 J, WT littermates and Ninj1–/– female (8–14 weeks old) mice were injected intraperitoneally with 1 × 107 CFU of C. albicans in 200 μL of dPBS. Female mice were chosen for the comparison, as male and female animals can show differential susceptibility to C. albicans infection78 potentially confounding the analyses of Ninj1 effects. Uninfected control mice were injected with 200 μL of sterile dPBS. Mice were monitored post-infection for distress in accordance with animal ethics. Mice were weighed at 0 h and 24 h post-infection. At 24 h post-infection, mice were euthanised by CO2 inhalation. Organs were harvested, weighed, and homogenised in 1 mL dPBS (supplemented with 10% FCS) using 3.2 mm stainless-steel beads in a bead mill. For homogenisation, ½ of the spleen and ½ of the kidney from each side were used. Serial dilutions were then prepared in dPBS and plated in triplicate on CHROMagar TM plates at 37 °C for 24 h. Fungal burden for each organ was then calculated based on colony counts from the lowest dilution that produced single, countable colonies. Serum amino acid extraction and analysis Female C57BL/6 J mice (Monash Animal Research Platform), aged 10–11 weeks and weighing approximately 18–22 g, were individually housed as part of a pair-feeding study requiring accurate monitoring of food intake. These mice had been previously allocated to an unrelated, aborted experiment and were therefore slightly older than typically used. Mice were fed ad libitum with Barastoc Research Feeds Mouse Breeder Cube chow diet, manufactured by Ridley AgriProducts, Victoria, Australia. Given that there are differences between female and male mice in C. albicans infection outcomes78, female mice were used for a relevant comparison of serum amino acids in infected and uninfected animals. Systemic C. albicans infection was induced via intravenous injection into the lateral tail vein using strain SC5314 at a dose of 1 × 10⁶ CFU per 20 g of body weight (equivalent to 5 × 10⁷ CFU/kg), administered in 100 µl sterile PBS. Mice were euthanized 24 h post-infection by cervical dislocation. Mice were decapitated immediately following euthanasia, and trunk blood was collected and centrifuged at 8,000 × g for 10 min at 4 °C to separate serum. Serum samples were aliquoted and stored at –80 °C for downstream amino acid profiling. For sample preparation, 25 µl of serum was mixed with 360 µl of ice-cold 100% methanol containing 5 µM of stable isotope-labeled amino acids. Samples were vortexed for 2 min, followed by the addition of 200 µl chloroform and incubation at 37 °C for 5 min with shaking. Subsequently, 400 µl of double-distilled water was added, and the mixture was vortexed again for 2 min. Samples were then centrifuged at maximum speed ( ≥ 12,000 × g) for 10 min at room temperature. A volume of 360 µl from the resulting aqueous phase was transferred to a new tube, evaporated with nitrogen (N2) gas until no liquid remained, and stored at –80 °C until analysis. Amino acids were quantified using LC-MS with a 13C stable isotope amino acid internal standard and external standards. Serum samples (2-5 uL) were extracted by the addition of 72 µL ice cold methanol (2 min shaking, Multiplate shaker, Biosan). Chloroform (50 µL) was added and samples incubated for 5 min at 37 °C with shaking. Water-soluble metabolites were extracted by the addition of 80 µL H2O followed by 2 min of vigorous shaking, 10 min centrifugation (maximum speed in a tabletop centrifuge) and removal of 50% of the aqueous phase into a new tube. Samples were then dried in a speed vac before storing. For analysis, samples were diluted 5 x (volume/original volume) with H2O. A 4 µL aliquot was mixed with an equal volume of heavy isotope standard (10 μM) before the addition of 32 μL of H2O (1:10 dilution). Thus, samples were diluted 1:100 (tissue w/v serum v/v) before comparison to standards by LC-MS analysis. Standards were assembled in the same way, resulting in final concentrations of 0.03 to 30 μM. A commercial AccQ-Tag Ultra Derivatization Kit (Waters) was used to prepare amino acids for LC-MS. To derivatise the amino acids, 5 μL final samples were mixed with 20 μL of Borate buffer, followed by the addition of 10 μL reagent (AccQ-Tag Reagent Waters). Samples were mixed instantly and incubated for 1 min at room temperature, then at 55 °C for 10 min. The samples were diluted by the addition of 165 μL of 5% acetonitrile in water before dispensing into an autosampler 96-well plate. Amino acids (4 μL injection volume) were separated using a Waters Acquity Premier BEH C18 50 mm×2.1 mm column using a gradient of 0.1% formic acid against 0.1% formic acid in acetonitrile. The mass spectra were acquired in positive mode with centroided data from 240–600 mz using either an Orbitrap Fusion or Q Exactive Plus spectrometer (Thermo Fisher Scientific). Skyline version 24.1 was used for quantification79, aiming for a calibration curve with a Pearson correlation coefficient of >0.99, sometimes requiring the exclusion of outliers. Statistical analysis All statistical analyses were performed using GraphPad Prism version 10.0 (GraphPad Software, San Diego, CA, USA). Specific statistical tests applied are described in the figure legends. A p-value of less than 0.05 was considered statistically significant throughout. Radar plot was created on RStudio using fmsb and ggplots2 packages. Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Description of Additional Supplementary Files Movie S1 Movie S2 Reporting summary Transparent Peer Review file Supplementary Information Description of Additional Supplementary Files Movie S1 Movie S2 Reporting summary Transparent Peer Review file Source data Source Data Source Data